☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Acasti Pharma
Acasti Pharma Reports Interim Results of GTX-104 in the PK Bridging Study for the Treatment of Subarachnoid Hemorrhage
December 3, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.